The Effect of Glasthma Syrup in Asthma: a study protocol for a triple-blind randomized controlled trial
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Asthma is a chronic disease, and the demand for herbal medicines in this field has increased in recent years. The new findings highlight the role of the gut-lung axis in the pathophysiology of asthma. Hence, this study will evaluate the safety and efficacy of Glasthma syrup, an herbal formula based on Persian medicine, in improving asthma and regulating intestinal permeability. The formula consists of five herbal ingredients that have anti-inflammatory effects on the respiratory tract, also known as gut tonics. Methods: The study will be conducted as a placebo-controlled, triple-blind, randomized trial. It will consist of a 4-week intervention followed by a 4-week follow-up period. The target sample size is 20 patients with moderate asthma aged 18 to 60 years. Eligible participants will be randomly assigned to either the experimental group or the control group in equal numbers. Patients in the experimental group will take Glasthma syrup (7.5 mL, twice a day), while patients in the control group will take a matching placebo. Both groups will receive a 4-week combination of a long-acting beta2 agonist and a leukotriene modulator as standard of care. Inhaled corticosteroids can be used as rescue medication as needed. Results: The primary outcomes are asthma symptom scale, lung function, and intestinal permeability. Secondary outcomes include quality of life, symptom recurrence rates, and blood tests. A safety assessment will also be conducted during the trial. Conclusion: In this trial, the effects of Glasthma syrup in patients with moderate asthma will be examined. The study will also assess the effects of the formulation on the gut-lung axis by simultaneously monitoring the gut permeability index, asthma symptoms, and lung function.
Abstract
Objectives: Asthma is a chronic disease, and the demand for herbal medicines in this field has increased in recent years. The new findings highlight the role of the gut-lung axis in the pathophysiology of asthma. Hence, this study will evaluate the safety and efficacy of Glasthma syrup, an herbal formula based on Persian medicine, in improving asthma and regulating intestinal permeability. The formula consists of five herbal ingredients that have anti-inflammatory effects on the respiratory tract, also known as gut tonics. Methods: The study will be conducted as a placebo-controlled, triple-blind, randomized trial. It will consist of a 4-week intervention followed by a 4-week follow-up period. The target sample size is 20 patients with moderate asthma aged 18 to 60 years. Eligible participants will be randomly assigned to either the experimental group or the control group in equal numbers. Patients in the experimental group will take Glasthma syrup (7.5 mL, twice a day), while patients in the control group will take a matching placebo. Both groups will receive a 4-week combination of a long-acting beta2 agonist and a leukotriene modulator as standard of care. Inhaled corticosteroids can be used as rescue medication as needed. Results: The primary outcomes are asthma symptom scale, lung function, and intestinal permeability. Secondary outcomes include quality of life, symptom recurrence rates, and blood tests. A safety assessment will also be conducted during the trial. Conclusion: In this trial, the effects of Glasthma syrup in patients with moderate asthma will be examined. The study will also assess the effects of the formulation on the gut-lung axis by simultaneously monitoring the gut permeability index, asthma symptoms, and lung function.
참고문헌 (34)
- Farahmand M, "Effectiveness of Echium amoenum on premenstrual syndrome : a randomized, double-blind, controlled trial", BMC Complement Med Ther, 20(1), pp.295~ (2020)
- Nejatbakhsh F, "Squill Oxymel, a traditional formulation from Drimia Maritima (L.) Stearn, as an add-on treatment in patients with moderate to severe persistent asthma: a pilot, triple-blind, randomized clinical trial", J Ethnopharmacol, 196, pp.186~192 (2017)
- Hosseini SA, "An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: a triple-blind, randomized placebo-controlled trial", Respir Med, 145, pp.28~34 (2018)
- Kaveh S, "The effect of compound honey syrup on clinical manifestation of the adult asthma patients : a randomized, double-blinded, placebo-controlled clinical trial", Trad Integr Med, 7(2), pp.195~202 (2022)
- Emtiazy M, "Investigating the effectiveness of the Trigonella foenum-graecum L. (fenugreek) seeds in mild asthma: a randomized controlled trial", Allergy Asthma Clin Immunol, 14, pp.19~ (2018)
- Javadi B, "Medicinal plants for the treatment of asthma : a traditional Persian medicine perspective", Curr Pharm Des, 23(11), pp.1623~1632 (2017)
- Tavakoli-Dastjerdi S, "Dietary modifications in fissurein-ano : a qualitative study based on Persian medicine", Curr Nutr Food Sci, 16(6), pp.860~865 (2020)
- Ghaemi H, "The effectiveness of a traditional Persian medicine preparation in the treatment of chronic cough : a randomized, double-blinded, placebo-controlled clinical trial", Complement Ther Med, 49, pp.102324~ (2020)
- Yue Y, "Wild jujube polysaccharides protect against experimental inflammatory bowel disease by enabling enhanced intestinal barrier function", Food Funct, 6(8), pp.2568~2577 (2015)
- Vaughan A, "COPD and the gut-lung axis : the therapeutic potential of fibre", J Thorac Dis, 17, pp.S2173~S2180 (2019)
- Dang AT, "Microbes, metabolites, and the gut-lung axis", Mucosal Immunol, 12(4), pp.843~850 (2019)
- Enaud R, "The gut-lung axis in health and respiratory diseases : a place for inter-organ and inter-kingdom crosstalks", Front Cell Infect Microbiol, 10, pp.9~ (2020)
- Marsland BJ, "The gut-lung axis in respiratory disease", Ann Am Thorac Soc, 12(Suppl), pp.S150~S156 (2015)
- Jorjani E, "Treasure of Khwarazm Shah" (1976), Entesharat-e Bonyade Farhang-e Iran
- Aghili SMH, "Aghili’s treatments" (2008), Research Institute for Islamic and Complimentary Medicine
- Jorjani SE, "KhofiAlaii (Hidden book of Alaii)" (1990), Ettela’at Press
- Mirsadraee M, "Effect of borago extract on moderate persistent asthma, a phase two randomized, double blind placebo-controlled clinical trial", Eur Respir J, 48(Suppl 60), pp.PA4116~ (2016)
- Jin J, "Antioxidant properties and reported ethnomedicinal use of the genus Echium (Boraginaceae)", Antioxidants (Basel), 9(8), pp.722~ (2020)
- Anushiravani M, "Comparing effectiveness of a combined herbal drug based on Echium amoenum with citalopram in the treatment of major depressive disorder", Curr Drug Discov Technol, 16(2), pp.232~238 (2019)
- Nelson JL, "Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome", JPEN J Parenter Enteral Nutr, 27(2), pp.98~104 (2003)
- Mirsadraee M, "Effect of Borago officinalis extract on moderate persistent asthma:a phase two randomized, double blind, placebo-controlled clinical trial", Tanaffos, 15(3), pp.168~174 (2016)
- Baars EW, "A comparative in vitro study of the effects of separate and combined products of Citrus e fructibus and Cydonia e fructibus on immunological parameters of seasonal allergic rhinitis", Mediators Inflamm, 2012, pp.109829~ (2012)
- Shakeri A, "A comparative study of ranitidine and quince (Cydonia oblonga mill) sauce on gastroesophageal reflux disease (GERD) in pregnancy: a randomised, open-label, activecontrolled clinical trial", J Obstet Gynaecol, 38(7), pp.899~905 (2018)
- Naeimi M, "Comparison of the efficacy of ranitidine and quince syrup on gastroesophageal reflux disease in children", Complement Ther Med, 45, pp.215~221 (2019)
- Aghili MH, "Khulasah al-Hikmah" (2008), Research Institute for Islamic and Complementary Medicine
- Gargari G, "Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake", FEMS Microbiol Ecol, 94(5), pp.fiy045~ (2018)
- de Souza RGM, "Nuts and human health outcomes : a systematic review", Nutrients, 9(12), pp.1311~ (2017)
- FitzGerald JM, "International severe asthma registry (ISAR): protocol for a global registry", BMC Med Res Methodol, 20(1), pp.212~ (2020)
- Rabbani GH, "Green banana and pectin improve small intestinal permeability and reduce fluid loss in Bangladeshi children with persistent diarrhea", Dig Dis Sci, 49(3), pp.475~484 (2004)
- Zhang HP, "Chinese herbal medicine formula for acute asthma : a multi-center, randomized, double-blind, proof-of-concept trial", Respir Med, 140, pp.42~49 (2018)
- Urata Y, "Treatment of asthma patients with herbal medicine TJ-96 : a randomized controlled trial", Respir Med, 96(6), pp.469~474 (2002)
- Juniper EF, "Development and validation of a questionnaire to measure asthma control", Eur Respir J, 14(4), pp.902~907 (1999)
- Grammatopoulou E, "An 18-item standardized Asthma Quality of Life Questionnaire-AQLQ(S)", Qual Life Res, 17(2), pp.323~332 (2008)
- Juniper EF, "Development and validation of the mini asthma quality of life questionnaire", Eur Respir J, 14(1), pp.32~38 (1999)